Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin
other · Food and Drug Administration · Rule · Published 1997-07-21 · 62 FR 38907
Document
Document number
97-19124
Federal Register citation
62 FR 38907
CFR reference
21 CFR 524
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1997-07-21
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Merck Research Laboratories, Division of Merck & Co., Inc. The supplemental NADA provides for topical use of ivermectin for control of infections of gastrointestinal roundworms for 14 days following use on cattle.